4.50

4.90% 0.21

Bolt Biotherapeutics Inc (BOLT)

Overview News Price History Financials Discussions Forecast

Bolt Biotherapeutics Inc stock is traded at $4.50, with a volume of 12,489. It is up +4.90% in the last 24 hours and down -8.16% over the past month. Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Previous Close:

$4.29

Open:

$4.465

24h Volume:

12,489

Relative Volume:

0.47

Market Cap:

$8.65M

Revenue:

$7.70M

Net Income/Loss:

$-33.38M

P/E Ratio:

-0.3655

EPS:

-12.3134

Net Cash Flow:

$-39.92M

1W Performance:

-2.91%

1M Performance:

-8.16%

6M Performance:

-18.63%

1Y Performance:

-46.43%

1-Day Range:

$4.26

$4.55

1-Week Range:

$4.21

$4.8784

52-Week Range:

$3.91

$9.376

Bolt Biotherapeutics Inc Stock (BOLT) Company Profile

Name

Bolt Biotherapeutics Inc

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

650-665-9295

Address

900 CHESAPEAKE DRIVE, REDWOOD CITY

Employee

Twitter

Next Earnings Date

2026-03-23

Latest SEC Filings

BOLT's Discussions on Twitter

Compare BOLT vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BOLT Bolt Biotherapeutics Inc	4.50	8.65M	7.70M	-33.38M	-39.92M	-12.31
VRTX Vertex Pharmaceuticals Inc	454.97	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	31.97B	606.42M	-1.28B	-997.58M	-6.403

Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Resumed	H.C. Wainwright	Buy
Jan-06-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-02-21	Initiated	Guggenheim	Buy
Mar-02-21	Initiated	Morgan Stanley	Overweight
Mar-02-21	Initiated	SVB Leerink	Outperform
Mar-02-21	Initiated	Stifel	Buy

View All

Bolt Biotherapeutics Inc Stock (BOLT) Latest News

Mar 25, 2026

CEO Change: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Mar 25, 2026

Bolt Biotherapeutics (BOLT) to Release Quarterly Earnings on Wednesday - Defense World

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Bolt Biotherapeutics, Inc. (BOLT) - Stock Titan

Mar 22, 2026

Buyout Rumor: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Buying & Technical Pattern Based Signals - baoquankhu1.vn

Mar 22, 2026

Market Outlook: Is Bolt Biotherapeutics Inc likely to announce a buybackEarnings Miss & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Market Leaders: Is Bolt Biotherapeutics Inc likely to announce a buyback2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 21, 2026

Sell Signal: Will Bolt Biotherapeutics Inc outperform its industry peersPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

What is the long term forecast for Bolt Biotherapeutics Inc stock2026 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026

Weekly Earnings: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Fundamentals Check: Does Bolt Biotherapeutics Inc have strong EBITDA margins2026 Bull vs Bear & Community Consensus Trade Signals - baoquankhu1.vn

Mar 17, 2026

Mar 14, 2026

Whats the outlook for Bolt Biotherapeutics Incs sector2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn

Mar 14, 2026

Mar 13, 2026

Market Outlook: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn

Mar 13, 2026

HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus

Mar 13, 2026

Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com

Mar 13, 2026

Mar 12, 2026

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget

Mar 12, 2026